UBS maintains Buy rating on Alvotech, lowers PT to $6 from $10.

Tuesday, Mar 24, 2026 10:49 am ET1min read
ALVO--

UBS maintains Buy rating on Alvotech, lowers PT to $6 from $10.

UBS maintains Buy rating on Alvotech, lowers PT to $6 from $10.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet